Records containing: Recurrent Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-02-01A Randomized Phase 2 Study of Rebeccamycin Analog in Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-01-25Phase I Study of a Recombinant Fowl Pox Vaccine rF-CEA (6D)/TRICOM Alone or With GM-CSF in Patients With Advanced CEA Expressing Adenocarinomas
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase II Study Of Single Agent Depsipeptide (FK228) In Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-01-24A Phase I/II Trial of Herceptin and ZD1839 (Iressa, NSC #715055, IND#61187) in Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu (erbB-2)
-
CLINICAL_TRIALS study record update · 2013-01-23Phase II Trial of STI571 in Metastatic Breast Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-23Phase II Trial Of PS-341 In Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-01-17A Phase II Study of Bevacizumab in Combination With Vinorelbine in Stage IV Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-01-16Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2013-01-16A Phase II Trial Of Gemcitabine And Triapine In Refractory Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2012-09-27A Phase I/II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Trastuzumab (Herceptin) in Patients With Advanced Metastatic and/or Local Chest Wall Recurrent Her-2 Amplified Breast Cancer
-
CLINICAL_TRIALS study record update · 2012-06-04A Phase I Trial Investigating the Safety and Immunogenicity of an Adenovirus Encoding Rat HER-2 Administered Intradermally to Patients With Metastatic or Locally Recurrent Breast Cancer
-
CLINICAL_TRIALS study record update · 2011-11-23A Safety and Efficacy Study of Doxil and Taxotere ± Herceptin in Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2011-05-11An Open-label, Multi-center Phase II Trial to Evaluate the Efficacy and Safety of Combination Chemotherapy With DoceTaxel(Detaxel) and Oxaliplatin(Oxalitin)in Recurrent or Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2011-05-06A Randomized Phase II Trial of Combination Anastrozole (NSC #719344) Plus ZD1839 (Iressa, NSC #715055, IND #61187) and of Combination Fulvestrant (NSC #719276) Plus ZD1839 in the Treatment of Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2011-04-04A Phase II Trial of Trastuzumab Plus Weekly Ixabepilone(BMS-247550) and Carboplatin in Patients With HER2/Neu-Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2009-06-16A Clinical Trial of Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) in Patients With Taxane-Pretreated Recurrent Breast Cancer